Cytokinetics, Incorporated (CYTK)
NASDAQ·Healthcare·Biotechnology
$61.45
+1.23%
Mkt Cap $8.67B
Analyst Ratings
Buy
19
Hold
0
Sell
0
Price Target (56 analysts)
$112.50
Range $95.00 – $140.00
Implied Upside
+83.1%
Consensus $112.50 vs current $61.45
NASDAQ·Healthcare·Biotechnology
$61.45
+1.23%
Mkt Cap $8.67B
Buy
19
Hold
0
Sell
0
Price Target (56 analysts)
$112.50
Range $95.00 – $140.00
+83.1%
Consensus $112.50 vs current $61.45